Kerr Hannah, Kinney Michael, Olaniyan Tolu, Alani Salako Olanrewaju, George Virginia, Engoru Benard, Mbukebam Mary, Kumwenda Millie, Sipilon Margaret, Shabangu Edward, Karway Thomas, Shankar Rohit
Queen's University Belfast, School of Medicine, Dentistry and Biomedical Science, Belfast, UK.
Queen's University Belfast, School of Medicine, Dentistry and Biomedical Science, Belfast, UK; Belfast Health and Social Care Trust, UK.
Epilepsy Behav. 2024 Dec;161:110048. doi: 10.1016/j.yebeh.2024.110048. Epub 2024 Sep 20.
Epilepsy prevalence in sub-Saharan Africa is high with a significant treatment gap. In this context, epilepsy presents substantial challenges to effective and safe reproductive and maternal healthcare. To improve this, it is important to understand the views and perceptions of healthcare professionals delivering epilepsy care to this population.
This study uses an online questionnaire which asked healthcare professionals (both from nursing and medical backgrounds) who work in sub-Saharan African countries to rate a set of pre-established options designed with the feedback of a local focus group of epilepsy experts from countries targeted. The questionnaire consisted of 21 questions and was a mix of multiple choice and Likert scale questions on managing reproductive health in women in local settings.
Of 203 healthcare professionals respondents from over 10 countries majority were doctors (48%) or nurses (36%). The Gambia (28.6%), Nigeria (22.2%), Cameroon (13.3%) and Zambia (9.4%) accounted for nearly three-quarters of respondents. Over half (54%) felt that they have the necessary training to counsel women with epilepsy on reproductive health and pregnancy. Only 40% reported they regularly discuss family planning. Carbamazepine was reported to be the most used anti-seizure medication (ASM) for childbearing age women. Key challenges outlined were epilepsy awareness among patients and their families, information deficit on ASMs and pregnancy and access to a sufficient range of ASMs.
Understanding the challenges faced by health professionals in sub-Sharan Africa, provides better comprehension of the specific "treatment-education gap" in counselling women with epilepsy on ASM risks and benefits.
撒哈拉以南非洲地区癫痫患病率很高,治疗缺口巨大。在此背景下,癫痫给有效且安全的生殖和孕产妇保健带来了重大挑战。为改善这种情况,了解为该人群提供癫痫护理的医护人员的观点和看法很重要。
本研究使用在线问卷,询问在撒哈拉以南非洲国家工作的医护人员(包括护理和医学背景),对一组根据目标国家当地癫痫专家焦点小组的反馈设计的既定选项进行评分。问卷由21个问题组成,包括多项选择题和李克特量表问题,涉及当地环境中女性生殖健康管理。
来自10多个国家的203名医护人员受访者中,大多数是医生(48%)或护士(36%)。冈比亚(28.6%)、尼日利亚(22.2%)、喀麦隆(13.3%)和赞比亚(9.4%)占受访者近四分之三。超过一半(54%)的人认为他们有必要的培训,为癫痫女性提供生殖健康和怀孕方面的咨询。只有40%的人报告说他们经常讨论计划生育。据报告,卡马西平是育龄妇女最常用的抗癫痫药物。概述的主要挑战包括患者及其家人对癫痫的认识、抗癫痫药物和怀孕方面的信息不足,以及获得足够种类的抗癫痫药物。
了解撒哈拉以南非洲地区卫生专业人员面临的挑战,有助于更好地理解在为癫痫女性提供抗癫痫药物风险和益处咨询方面具体的“治疗-教育缺口”。